Hawaii 2023 Regular Session

Hawaii House Bill HR186 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	HOUSE OF REPRESENTATIVES H.R. NO. 186 THIRTY-SECOND LEGISLATURE, 2023 STATE OF HAWAII HOUSE RESOLUTION requesting the Department of Health to conduct a social and financial assessment of proposed mandatory health insurance coverage for weight management medication.
2	2
3	3	HOUSE OF REPRESENTATIVES H.R. NO. 186
4	4	THIRTY-SECOND LEGISLATURE, 2023
5	5	STATE OF HAWAII
6	6
7	7	HOUSE OF REPRESENTATIVES
8	8
9	9	H.R. NO.
10	10
11	11	186
12	12
13	13	THIRTY-SECOND LEGISLATURE, 2023
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29	HOUSE RESOLUTION
30	30
31	31
32	32
33	33
34	34
35	35	requesting the Department of Health to conduct a social and financial assessment of proposed mandatory health insurance coverage for weight management medication.
36	36
37	37
38	38
39	39
40	40
41	41	WHEREAS, the National Institutes of Health has reported that obesity and being overweight are now the second leading cause of death nationally, with an estimated three hundred thousand deaths a year attributed to the epidemic; and WHEREAS, obesity increases the risk for chronic diseases and conditions, including high blood pressure, heart disease, certain cancers, arthritis, mental illness, lipid disorders, sleep apnea, and type 2 diabetes; and WHEREAS, clinicians increasingly recognize that obesity is closely linked to genetics and environmental factors; and WHEREAS, more than half of Medicare beneficiaries are treated for five or more chronic conditions per year; and WHEREAS, the rate of obesity among Medicare beneficiaries doubled from 1987 to 2002 and nearly doubled again by 2016, with Medicare spending on individuals with obesity during that time rising proportionately to reach $50 billion in 2014; and WHEREAS, on average, a Medicare beneficiary with obesity costs $2,018 more than a healthy-weight beneficiary; and WHEREAS, Senate Bill No. 1020, introduced in the Regular Session of 2023, proposes to expand existing health insurance mandates to cover weight management medication for persons who are obese or overweight with one or more related comorbidities; now, therefore, BE IT RESOLVED by the House of Representatives of the Thirty-second Legislature of the State of Hawaii, Regular Session of 2023, that the Department of Health is requested to conduct an impact assessment report of mandating health insurance coverage for weight management medication as proposed in Senate Bill No. 1020, introduced in the Regular Session of 2023; and BE IT FURTHER RESOLVED that the Department of Health is further requested to include in its assessment the impact of section 1311(d)(3) of the federal Patient Protection and Affordable Care Act (PPACA) on Senate Bill No. 1020, or similar legislation that includes but is not limited to the additional cost of any benefits beyond the essential health benefits of Hawaii's qualified health plans under the PPACA; and BE IT FURTHER RESOLVED that the Department of Health is also requested to determine how many qualified health plans are available in Hawaii, including plans offered by health maintenance organizations; the individual or group enrollment in these plans; and the actuarial cost of the defrayment to the State for the reimbursement of weight management medication; and BE IT FURTHER RESOLVED that the Department of Health is requested to submit a report on its findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2024; and BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Department of Health and Insurance Commissioner, who is requested to transmit copies to each insurer in the State that issues health insurance policies. OFFERED BY: _____________________________ Report Title: Department of Health; Social and Financial Impact Study; Insurance Coverage; Weight Management Medication
42	42
43	43	WHEREAS, the National Institutes of Health has reported that obesity and being overweight are now the second leading cause of death nationally, with an estimated three hundred thousand deaths a year attributed to the epidemic; and
44	44
45	45
46	46
47	47	WHEREAS, obesity increases the risk for chronic diseases and conditions, including high blood pressure, heart disease, certain cancers, arthritis, mental illness, lipid disorders, sleep apnea, and type 2 diabetes; and
48	48
49	49
50	50
51	51	WHEREAS, clinicians increasingly recognize that obesity is closely linked to genetics and environmental factors; and
52	52
53	53
54	54
55	55	WHEREAS, more than half of Medicare beneficiaries are treated for five or more chronic conditions per year; and
56	56
57	57
58	58
59	59	WHEREAS, the rate of obesity among Medicare beneficiaries doubled from 1987 to 2002 and nearly doubled again by 2016, with Medicare spending on individuals with obesity during that time rising proportionately to reach $50 billion in 2014; and
60	60
61	61
62	62
63	63	WHEREAS, on average, a Medicare beneficiary with obesity costs $2,018 more than a healthy-weight beneficiary; and
64	64
65	65
66	66
67	67	WHEREAS, Senate Bill No. 1020, introduced in the Regular Session of 2023, proposes to expand existing health insurance mandates to cover weight management medication for persons who are obese or overweight with one or more related comorbidities; now, therefore,
68	68
69	69
70	70
71	71	BE IT RESOLVED by the House of Representatives of the Thirty-second Legislature of the State of Hawaii, Regular Session of 2023, that the Department of Health is requested to conduct an impact assessment report of mandating health insurance coverage for weight management medication as proposed in Senate Bill No. 1020, introduced in the Regular Session of 2023; and
72	72
73	73
74	74
75	75	BE IT FURTHER RESOLVED that the Department of Health is further requested to include in its assessment the impact of section 1311(d)(3) of the federal Patient Protection and Affordable Care Act (PPACA) on Senate Bill No. 1020, or similar legislation that includes but is not limited to the additional cost of any benefits beyond the essential health benefits of Hawaii's qualified health plans under the PPACA; and
76	76
77	77
78	78
79	79	BE IT FURTHER RESOLVED that the Department of Health is also requested to determine how many qualified health plans are available in Hawaii, including plans offered by health maintenance organizations; the individual or group enrollment in these plans; and the actuarial cost of the defrayment to the State for the reimbursement of weight management medication; and
80	80
81	81
82	82
83	83	BE IT FURTHER RESOLVED that the Department of Health is requested to submit a report on its findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2024; and
84	84
85	85
86	86
87	87	BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Department of Health and Insurance Commissioner, who is requested to transmit copies to each insurer in the State that issues health insurance policies.
88	88
89	89
90	90
91	91
92	92
93	93
94	94
95	95	OFFERED BY: _____________________________
96	96
97	97
98	98
99	99	OFFERED BY:
100	100
101	101	_____________________________
102	102
103	103
104	104
105	105
106	106
107	107	Report Title:
108	108
109	109	Department of Health; Social and Financial Impact Study; Insurance Coverage; Weight Management Medication